Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

ClinicalTrials.gov ID: NCT05035082

Public ClinicalTrials.gov record NCT05035082. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 2:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

REALYSE - Comparative Effectiveness of Once-daily Oral Semaglutide Versus Any Other Oral Glucose-lowering Medication in a Real-world Adult Population With Type 2 Diabetes on Metformin Monotherapy in US Based Health Care Systems - a Pragmatic Randomized Trial

Study identification

NCT ID
NCT05035082
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,020 participants

Conditions and interventions

Interventions

  • oral glucose-lowering medications (commercially available) Drug
  • semaglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2021
Primary completion
Jun 17, 2025
Completion
Jun 17, 2025
Last update posted
Nov 24, 2025

2021 – 2025

United States locations

U.S. sites
25
U.S. states
11
U.S. cities
23
Facility City State ZIP Site status
Stewart Medical Group Alhambra California 91801
FDRC Costa Mesa California 92627
Scripps Whittier Diabetes Inst La Jolla California 92037
Raincross Medical Group Riverside California 92506
Reyes Clinical Research, Inc Miami Florida 33175
DC Research Works Marietta Georgia 30060
Urban Family Practice Assoc Marietta Georgia 30067
Macoupin Research Group Gillespie Illinois 62033
UnityPoint Health-Diabetes Care Center Peoria Illinois 61603
Endeavor Health Skokie Illinois 60077
Kernodle Clin Dpt-Pvt Diagnost Burlington North Carolina 27215
OnSite Clinical Solutions, LLC_Charlotte Charlotte North Carolina 28277
WakeMed Garner Hlthplx Garner North Carolina 27529
Clinical Research of Gastonia Gastonia North Carolina 28054
Valley Weight Loss Clinic Fargo North Dakota 58104
Diab & Endo Assoc of Stark Co Canton Ohio 44718
Central Ohio Clinical Research LLC Columbus Ohio 43213
Jefferson Endocrinology Assocs Philadelphia Pennsylvania 19107-6810
Tristar Clin Investigations, PC Philadelphia Pennsylvania 19114
Preferred Primary Care Physicians_Pittsburgh Pittsburgh Pennsylvania 15236
AnMed Health IMA Anderson South Carolina 29621
Baylor Scott & White Res Inst Dallas Texas 75246
Hill Country Medical Associates New Braunfels Texas 78130
DCT-Stone Oak San Antonio Texas 78258
Chrysalis Clinical Research St. George Utah 84790

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05035082, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2025 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05035082 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →